Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 35 for “"SphK2"”.

  1. Targeting the SPHK2-STING Axis in Triple-Negative Breast Cancer

    … kinase 1 (SPHK1) and sphingosine kinase 2 (SPHK2). SPHK2 is elevated in TNBC compared to normal breast tissue. SPHK2 has been shown previously to inhibit STING in a lung injury model, and it suppresses anti-tumor immunity. The SPHK2-STING axis has not been elucidated or pharmacologically …

    ku Repository record for Targeting the SPHK2-STING Axis in Triple-Negative Breast Cancer (opens in a new tab)

  2. Sex-Specific Regulation of MASH and Hepatocellular Carcinoma: A Role of SphK2 in Females

    … we previously identified sphingosine Kinase 2 (SphK2) to protect females from MASH-driven HCC. This study first performed differential gene expression analysis on human liver cohorts to examine sex-specific differences in gene expression between males and females and their corresponding …

    vcu Repository record for Sex-Specific Regulation of MASH and Hepatocellular Carcinoma: A Role of SphK2 in Females (opens in a new tab)

  3. The Role of Sphingosine Kinase 2 in Cell Growth and Apoptosis

    … when overexpressed in mouse NIH 3T3 fibroblasts SphK2 enhances caspase-dependent apoptosis in response to serum deprivation, independently of S1P receptors. Sequence analysis revealed that SphK2 contains a 9 amino acid motif similar to that present in BH3-only proteins. Studies showed that the …

    vcu Repository record for The Role of Sphingosine Kinase 2 in Cell Growth and Apoptosis (opens in a new tab)

  4. Virus interactions with the sphingolipid network : sphingosine kinase 2 in immunosuppression, immunopathology, and viral propagation

    … persistent infection in mice, one SphK isoform, SphK2, functions to limit CD4+ T cell responses, which aids in the establishment of virus-induced immunosuppression and viral persistence. The infection of SphK2-deficient (Sphk2-/-) mice with LCMV resulted in kidney disease and ultimately …

    missouri Repository record for Virus interactions with the sphingolipid network : sphingosine kinase 2 in immunosuppression, immunopathology, and viral propagation (opens in a new tab)

  5. Design and Synthesis of Orally Bioavailable Sphingosine Kinase 2 Selective Inhibitors

    … enzyme's sphingosine kinase 1 and 2 (SphK1 and SphK2). Inhibition of SphK1 and SphK2 results in the manipulation of S1P levels, which has been shown to be therapeutic in various animal models of disease. While there are multiple examples of potent SphK1-selective and dual SphK1/2 inhibitors, …

    vt Repository record for Design and Synthesis of Orally Bioavailable Sphingosine Kinase 2 Selective Inhibitors (opens in a new tab)

  6. The Role of Sphingosine Kinase 2 in Alcoholic Liver Disease

    … We have discovered that sphingosine kinase 2 (SphK2) deficient (SphK2-/-) mice on an alcohol diet exhibit increased steatosis and inflammation compared to wild type mice. Sphingosine 1-phosphate receptor 2 (S1PR2) and SphK2 have been previously shown to play a key role in nutrient metabolism …

    vcu Repository record for The Role of Sphingosine Kinase 2 in Alcoholic Liver Disease (opens in a new tab)

  7. SPHINGOSINE KINASE 2 DEPLETION DYSREGULATES HEPATIC REDOX METABOLISM AND ENHANCES INFLAMMATION IN EARLY METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH)

    … isoenzymes, sphingosine kinase (SphK)1 and SphK2. The localization of the SphK enzyme dictates S1P function. While cytosolic SphK1-generated S1P is well-characterized, nuclear and mitochondrial SphK2-generated S1P is less known. Moreover, SphK2 depletion effects on cellular redox processes …

    vcu Repository record for SPHINGOSINE KINASE 2 DEPLETION DYSREGULATES HEPATIC REDOX METABOLISM AND ENHANCES INFLAMMATION IN EARLY METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH) (opens in a new tab)

  8. Structure Activity Relationship Studies on Isoform Selective Sphingosine Kinase Inhibitors

    … two isoforms of sphingosine kinase (SphK1 and SphK2). Therefore, SphKs are a potential therapeutic target; however, the physiological role of SphK2 is still emerging. In order to determine the role of SphK2 in vivo, more potent and selective small molecule inhibitors of SphK2, as well as dual …

    vt Repository record for Structure Activity Relationship Studies on Isoform Selective Sphingosine Kinase Inhibitors (opens in a new tab)

  9. Structure-activity relationship studies and biological evaluation of selective sphingosine kinase inhibitors

    … the structure-activity relationships (SAR) of SphK2 through an iterative process of synthesis and biological testing. First, an SAR structured around the head and linker region of our lead molecule, SLR080811, was performed. SLR080811 has a Ki of 1.3 µM and is 5-fold selective for SphK2. The …

    vt Repository record for Structure-activity relationship studies and biological evaluation of selective sphingosine kinase inhibitors (opens in a new tab)

  10. Structure-Activity Relationship Studies of Sphingosine Kinase Inhibitors and Mitochondrial Uncouplers

    … and SphK exists as two isoforms-"SphK1 and SphK2, which differ with respect to their cellular activity and localization. As the key mediators in the synthesis of S1P, SphKs have attracted attention as viable targets for pharmaceutical inhibition. To validate their potential as therapeutic …

    vt Repository record for Structure-Activity Relationship Studies of Sphingosine Kinase Inhibitors and Mitochondrial Uncouplers (opens in a new tab)

  11. Targeting Sphingosine Kinase 2 as a Treatment for Cholangiocarcinoma

    … (S1PR2) and sphingosine kinase 2 (SphK2). Recently, a competitive SphK2 inhibitor, ABC294640, has been approved for clinical trial. ABC294640 has the potential to treat CCA, which is support by a phase I clinical study that was able to temporarily treat a patient suffering from …

    vcu Repository record for Targeting Sphingosine Kinase 2 as a Treatment for Cholangiocarcinoma (opens in a new tab)

  12. SPHINGOSINE KINASE INHIBITION AMELIORATES CHRONIC HYPOPERFUSION-INDUCED WHITE MATTER LESIONS

    … AND INDUCED HYPOXIA INDUCIBLE FACTOR (HIF)-1A, SPHK2, S1P, AND NG2 UP-REGULATION TOGETHER WITH ACCUMULATION OF WML. IN ADDITION, SPHK INHIBITOR SKI-II SHOWED PARTIAL REVERSAL OF SPHK2, S1P AND NG2 ELEVATION AND AMELIORATION OF WML. IN AN IN VITRO MODEL OF HYPOXIA, SKI-II REVERSED THE SUPPRESSION …

    nus Repository record for SPHINGOSINE KINASE INHIBITION AMELIORATES CHRONIC HYPOPERFUSION-INDUCED WHITE MATTER LESIONS (opens in a new tab) Download file for SPHINGOSINE KINASE INHIBITION AMELIORATES CHRONIC HYPOPERFUSION-INDUCED WHITE MATTER LESIONS (opens in a new tab)

  13. Anti-Tumor Functions of Sphingosine Kinase 1 and Sphingosine Kinase 2 in Breast Cancer Development

    … that produces S1P, sphingosine kinase 2 (SphK2), shown to greatly increases circulating levels of S1P, markedly suppressed syngeneic triple-negative BC growth and pulmonary metastasis. In these lungs, immunosuppressive PMN-MDSCs and Tregs decreased and immunostimulant T effector, NK and M1 …

    vcu Repository record for Anti-Tumor Functions of Sphingosine Kinase 1 and Sphingosine Kinase 2 in Breast Cancer Development (opens in a new tab)

  14. Design, synthesis, and biological evaluation of selective sphingosine kinase inhibitors

    … as two different isoforms, namely SphK1 and SphK2, which play different roles inside the cell. The dearth of isoenzyme-selective inhibitors has been a stumbling block for probing the exact roles of these two isoforms in disease progression. This report documents our efforts in developing …

    vt Repository record for Design, synthesis, and biological evaluation of selective sphingosine kinase inhibitors (opens in a new tab)

  15. The role of Sphingosine kinase in inflammatory diseases

    … cells. On the other hand, mice administered with SphK2 siRNA develop a more aggressive disease. Together, these results demonstrate the distinct immunomodulatory roles of SphK1 and SphK2 in the development of inflammatory diseases. These findings raise the possibility that drugs targeting SphK1 …

    nus Repository record for The role of Sphingosine kinase in inflammatory diseases (opens in a new tab) Download file for The role of Sphingosine kinase in inflammatory diseases (opens in a new tab)

  16. Identification of Familial Wilms Tumor Predisposition Genes Using Whole Genome Sequencing

    … mutations in DICER1 (4% of families) and SPHK2. Functional studies demonstrate that the missense mutation identified in SPHK2 does not have an effect on apoptosis or proliferation, but instead alters SPHK2 subcellular localization and expression of target genes. Our analysis resulted in …

    uthsc Repository record for Identification of Familial Wilms Tumor Predisposition Genes Using Whole Genome Sequencing (opens in a new tab)

  17. Understanding Molecular Interactions: Application of HINT-based Tools in the Structural Modeling of Novel Anticancer and Antiviral Targets, and in Protein-Protein Docking

    … modeling of human sphingosine kinase 2 (SphK2, a novel anticancer target) and binding mode determination of an isoform selective thiazolidine-2,4-dione (TZD) analog; ii) structural modeling of human cytomegalorvirus (HCMV) alkaline nuclease (AN) UL98 (a novel antiviral target) and …

    vcu Repository record for Understanding Molecular Interactions: Application of HINT-based Tools in the Structural Modeling of Novel Anticancer and Antiviral Targets, and in Protein-Protein Docking (opens in a new tab)

  18. Roles of Sphingosine Kinases and Regulation of Sphingosine 1-Phosphate in Glioblastoma Multiforme Cells

    … suppressing the gene expression of SphK2 produced a more potent inhibition of cell proliferation, reduction of viability, and G1 cell cycle arrest than suppressing SphK1. We subsequently tested if a reduced intracellular S1P level was responsible for such anti-proliferative effects. …

    unsw Repository record for Roles of Sphingosine Kinases and Regulation of Sphingosine 1-Phosphate in Glioblastoma Multiforme Cells (opens in a new tab)

Page 1 of 2